Context Therapeutics
Price & Volume
Stats
See more52W Range | $0.34-$3.62 |
Market Cap | $35.1M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.48 |
News
See moreYahoo Finance • 2 months ago
Endometrial Cancer Market Share Analysis and Industry Trends (2026-2031) Featuring Merck, Eisai, Karyopharm Therapeutics, Context Therapeutics, Seagen and More
Yahoo Finance • 2 months ago
Context Expands Q2 Net Loss As Pipeline Advances; Stock Drops 23% In Overnight Market
Yahoo Finance • 3 months ago
Maxim Says Context Therapeutics (CNTX)’s Share Pullback Is an Overreaction; Remains Bullish
Yahoo Finance • 6 months ago
Context Therapeutics rises on FDA fast track status for lead asset
About
CEO | Mr. Martin A. Lehr |
CFO | Ms. Jennifer Minai-Azary |
Address | 2001 Market Street, Philadelphia, PA, United States, 19103 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 15 |